Fingolimod 0.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4G0B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,776
Award facts
- Contract value 100% obligated
- $15,776.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Fingolimod 0.5 mg capsules (30-count package) with a contract value of $15,776.47. The award is a firm fixed-price delivery order with no set-aside designation, indicating competitive award against other qualified vendors. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026, which serves as the comprehensive vehicle for pharmaceutical and medical supply deliveries supporting military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products across multiple therapeutic domains, including neurological treatments, diabetes medications, pain management pharmaceuticals, and specialized medical supplies. Under its prime indefinite delivery vehicle with the DLA, the company supplies brand-name and generic medications, vaccines, syringes, vials, and test kits to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26F4G0B?
SPE2DR26F4G0B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4G0B worth?
The government has obligated $15,776 on SPE2DR26F4G0B.
Is contract SPE2DR26F4G0B an order under another contract?
Yes. SPE2DR26F4G0B is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4G0B competed?
The extent of competition for SPE2DR26F4G0B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award